Carlsmed, Inc.
CARL
$16.28
$0.070.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | 98.39% | 98.70% | 100.33% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 98.39% | 98.70% | 100.33% | ||
| Cost of Revenue | 75.61% | 111.59% | 79.54% | ||
| Gross Profit | 106.90% | 94.41% | 108.41% | ||
| SG&A Expenses | 69.99% | 62.88% | 77.88% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 53.89% | 49.88% | 52.74% | ||
| Operating Income | -16.18% | -2.90% | -7.32% | ||
| Income Before Tax | -9.13% | -7.79% | -5.18% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -9.13% | -7.79% | -5.18% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -9.13% | -7.79% | -5.18% | ||
| EBIT | -16.18% | -2.90% | -7.32% | ||
| EBITDA | -15.61% | -2.50% | -7.37% | ||
| EPS Basic | 80.33% | 4.81% | -7.73% | ||
| Normalized Basic EPS | 78.83% | 4.80% | 2.23% | ||
| EPS Diluted | 80.33% | 4.81% | -7.73% | ||
| Normalized Diluted EPS | 78.83% | 4.80% | 2.23% | ||
| Average Basic Shares Outstanding | 415.61% | 13.24% | 7.58% | ||
| Average Diluted Shares Outstanding | 415.61% | 13.24% | 7.58% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||